Mount Sinai Cancer Center ( Site 0029) — Miami Beach, Florida

Public research footprint of Mount Sinai Cancer Center ( Site 0029), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Non-small Cell Lung Cancer · Metastatic Colorectal Cancer · Endometrial Neoplasms · Metastatic Castration-resistant Prostate Cancer (mCRPC)

Recently updated registry entries

NCT07318558 — A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer… (Recruiting)
NCT05217446 — A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to… (Active Not Recruiting)
NCT04634877 — Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Mount Sinai Cancer Center ( Site 0029)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.